BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8031159)

  • 1. [Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer].
    Sasagawa T; Ho N; Endo T; Sekine T; Sugiyama K; Tomidokoro T; Hatakeyama S; Togashi M; Onuki K; Katagiri J
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1179-85. PubMed ID: 8031159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
    Sasai T; Kurihara M; Kubo Y; Nakano S; Kamano T; Taguchi S; Fukuyama E; Suwa T; Miyoshi K; Oda K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):141-6. PubMed ID: 3122666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies].
    Inoue Y; Nasu H; Nakamura J; Arakawa H; Masamune O; Yamada N; Furuya M; Ookubo M; Mukojima T; Koizumi R
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3567-72. PubMed ID: 2510604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized-controlled study of treatment with UFT-MMC or UFT-ACR in advanced gastric cancer. Tohoku Study Group of Cancer Treatment for the Digestive Organs].
    Goto Y; Toyota T; Asaki S; Satoh J; Kikuchi T; Koizumi M; Ohkubo T; Nomura N; Mochizuki F; Taima T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2227-33. PubMed ID: 2500068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
    Kiyohashi A; Kurihara M; Yoshida S; Ohkubo T; Suga S
    Jpn J Clin Oncol; 1993 Feb; 23(1):41-5. PubMed ID: 8459640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
    Sakata Y; Chiba Y; Sato T; Kimura M; Fukushi G; Matsukawa M; Wada K; Aoyama H; Sawada Y; Fukushi M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):195-201. PubMed ID: 1736831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
    Sakata Y; Munakata A; Baba T; Saitoh S; Itoh T; Tamura Y; Furukohori N; Suzuki H; Kimura T; Kawata K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2065-71. PubMed ID: 3134859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT].
    Sugimachi K; Okamura T; Furusawa M; Saku M; Noda S; Matsusaka T; Teraoka H; Toda T; Oka N; Inokuchi K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2953-7. PubMed ID: 3140734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
    Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
    Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [UFTPM (UFT + CDDP + MMC) therapy for progressive stomach cancer. Research Association of Progressive Stomach Cancer].
    Iwazaki R; Yasutake K; Fukuyama Y; Hasegawa K; Koizumi W; Sasai T; Kurihara M; Kubo Y; Ishikawa K; Hayakawa M
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1179-85. PubMed ID: 8333746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].
    Koda K; Nakazawa O; Morita K; Kure T; Terada S; Matsunaga T; Tsuji Y; Miyazaki E; Nakajima K; Morii K
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1893-900. PubMed ID: 2118336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of unresectable Borrmann's type IV stomach cancer].
    Kurihara M; Izumi T; Sasaki Y; Maruyama T; Miyasaka K
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2468-77. PubMed ID: 6418075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer--(Part 2). Comparisons between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Kuroda Y; Arima S; Ohsato K; Ohkuma R; Fukuyama N; Yamanouchi A; Hisatsugu T; Yamamoto H; Nakamura Y; Abe R
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2235-40. PubMed ID: 2500069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer.
    Nakagoe T; Ishikawa H; Sawai T; Tuji T; Ayabe H; Eida K; Nogawa T; Nakamura Y; Kunisaki T; Tobinaga K; Furukawa M; Ino M
    Anticancer Res; 2000; 20(2B):1069-75. PubMed ID: 10810399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
    Danno M; Shiroto H; Kunii Y; Ishibiki K; Yamamura Y; Sakamoto Y; Tamura Y; Kunitomo K; Kumashiro R;
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):195-203. PubMed ID: 11242646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interim report of JFMC study no. 23--phase III randomized clinical trial on the effectiveness of low-dose cisplatin plus 5-FU as a postoperative adjuvant chemotherapy for advanced gastric cancer].
    Saji S; Toge T; Kurosu Y; Hirata K; Gochi A; Tominaga S; Inokuchi K
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2499-507. PubMed ID: 12506472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.